Rigetti Computing’s tiny revenues, conditional CHIPS Act funding and long‑term execution risk could make its stock a trap rather than a bargain.
Rigetti Computing reported first‑quarter 2026 revenue of $4.4 million with an operating loss of $26 million and an adjusted net loss of $14.7 million, and second‑quarter revenue of $5.1 million with an operating loss of $28.1 million and an adjusted net loss of $16 million. The company ended Q2 with $541.3 million in cash and investments and no debt, a market cap of about $5.5 billion, and a gross margin of roughly –3,975 percent. Its Cepheus‑1‑108Q chiplet‑based quantum chip is available via cloud but has not yet generated sustainable cash flow.
The firm signed a definitive agreement with the U.S. Department of Commerce for up to $100 million in CHIPS Act funding. $43.9 million has been made available, while the remaining $56.1 million is split into two tranches tied to specific technical milestones, and the government retains the right to claw back funds for non‑performance. In exchange, Rigetti will issue about 7.74 million shares at an implied $12.92 per share, giving the department a minority equity stake and diluting existing shareholders.
Management describes its roadmap in multi‑year terms, noting a three‑year government program aimed at utility‑scale quantum computing with key system deliveries not expected until 2027. While customers have praised the reliability of the 108‑qubit system, the company acknowledges that quantum advantage for practical workloads remains distant. The article warns that if milestones slip or better‑funded rivals advance, investors could face years of waiting for commercial traction.